Chemical Biology Ventures receives Elsevier Atlas award for publication impact for its review of "Alternatives to Antibiotics".
By Lloyd Czaplewski, Mar 19 2016 03:25PM
The award was presented to Lloyd Czaplewski, co-authors and the sponsors, the Wellcome Trust & the Department of Health (England) who were represented by Mike Turner, Head of Infection and Immunobiology at the Trust, by John McConnell, Editor in Chief of Lancet Infectious Diseases at the SMI Superbugs and Superdrugs conference in London on 17 March 2016
http://www.thelancet.com/…/PIIS1473-3099(15)00466-1/abstract
https://www.elsevier.com/atlas/home


Chemical Biology Ventures News